STOCK TITAN

Doximity (DOCS) Form 144: Proposed 5,000-Share Sale via Morgan Stanley

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 filed for proposed sale of common stock. The notice reports a proposed sale of 5,000 shares through Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $315,000 and states total shares outstanding of 187,299,459. The securities are shown as acquired on 08/08/2025 by a stock option exercise from the issuer and paid in cash.

The filing also discloses prior sales by the same account in the past three months: 5,000 shares sold on 07/11/2025 for $300,200 and 10,000 shares sold on 06/25/2025 for $600,000. The signer attests they have no undisclosed material information as of the notice.

Positive

  • Rule 144 notice filed showing compliance with required insider sale disclosure
  • Brokered sale through Morgan Stanley Smith Barney on the NYSE is specified
  • Acquisition method disclosed as a stock option exercise with cash payment

Negative

  • Recent insider selling: 15,000 shares sold in the past three months for total gross proceeds of $900,200
  • Filer identification fields are incomplete in the provided content (CIK/contact information not shown)

Insights

TL;DR: Routine insider sale notice for 5,000 shares acquired by option exercise; prior month sales total 15,000 shares.

The Form 144 documents a proposed sale of 5,000 common shares via Morgan Stanley Smith Barney on the NYSE, valued at $315,000. The shares were acquired by a stock option exercise and paid in cash on the stated acquisition date. The filing also records two recent dispositions totaling 15,000 shares for combined gross proceeds of $900,200. Based solely on the data in the filing, this is a compliance disclosure of insider selling rather than a corporate operational update.

TL;DR: Filing shows compliance with Rule 144 and an attestation regarding material nonpublic information.

The notice includes the required attestation that the filer does not possess undisclosed material adverse information. It records acquisition by option exercise and indicates sale execution through a registered broker. The form as provided omits specific filer contact/CIK details in the content tables, though transaction details are present. From a governance perspective, the document is a standard disclosure of insider selling activity.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does the DOCS Form 144 report?

The filing reports a proposed sale of 5,000 common shares via Morgan Stanley Smith Barney on the NYSE with an aggregate market value of $315,000.

How were the shares to be sold acquired?

The securities are shown as acquired on 08/08/2025 by a stock option exercise from the issuer, with payment in cash.

Has the filer sold shares recently?

Yes. The filing records sales of 5,000 shares on 07/11/2025 for $300,200 and 10,000 shares on 06/25/2025 for $600,000.

What broker is handling the proposed sale?

The proposed sale is listed as being handled by Morgan Stanley Smith Barney LLC, Executive Financial Services.

Does the filing state whether the filer holds material nonpublic information?

The signer represents by signing the notice that they do not know any material adverse information about the issuer that has not been publicly disclosed.
Doximity Inc

NYSE:DOCS

DOCS Rankings

DOCS Latest News

DOCS Latest SEC Filings

DOCS Stock Data

7.27B
134.21M
2.29%
90.53%
2.51%
Health Information Services
Services-computer Programming Services
Link
United States
SAN FRANCISCO